HIKMA PHARMACEUTICALS USA INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical manufacturer

$250,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (213697), not by name.

Firms hired 1

APCO WORLDWIDE LLC $250,000 6 filings

Reported by year 2 years

2026 $90,000 2 filings
2025 $160,000 4 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

HOUSE OF REPRESENTATIVES 6
SENATE 6
Commerce, Dept of (DOC) 4
Health & Human Services, Dept of (HHS) 4
Office of Management & Budget (OMB) 2
U.S. Trade Representative (USTR) 2
State, Dept of (DOS) 1

Recent filings 6 total

Q2

APCO WORLDWIDE LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 17, 2026

View → Q1

APCO WORLDWIDE LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4

APCO WORLDWIDE LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $40,000 income · posted Jan 15, 2026

View → Q3

APCO WORLDWIDE LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000 income · posted Oct 17, 2025

View → Q2

APCO WORLDWIDE LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 15, 2025

View → Q1

APCO WORLDWIDE LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.